NEOL: NeoPharm, Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : NEOL: NeoPharm, Inc.

Public Reply Prvt Reply Mark as Last Read File

Next 10PreviousNext

From: Gulo	11/23/2004 11:02:05 PM
	Read Replies (1) of 8

The recent news release caught my interest. I'll post some stuff as part of my DD on NEOL. Here's a start... Data from 2003 indicating increased survival. ncbi.nlm.nih.gov Slide 28 of the following presentation shows the importance of proper catheter placement: neophrm.com This is the Phase I/II trial clinicaltrials.gov This is the Phase III trial curently underway clinicaltrials.gov The competition: Xenova got 37 weeks survival (v 26) in their Phase II and just launched Phase III. xenova.co.uk xenova.co.uk

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Next 10PreviousNext